Publications by authors named "Elina Cho"
Background: Major society guidelines recommend transarterial chemoembolization (TACE) as the standard of care for intermediate-stage hepatocellular carcinoma (HCC) patients. However, predicting treatment response remains challenging.
Aims: As artificial intelligence (AI) may predict therapeutic responses, this systematic review aims to assess the performance and effectiveness of radiomics and AI-based models in predicting TACE outcomes in patients with HCC.
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis.
Clin Gastroenterol Hepatol
October 2024
Article Synopsis
- Chronic liver disease is a significant risk factor for cholangiocarcinoma (CCA), but its prevalence among CCA patients was previously unclear.
- A meta-analysis included data from 118,068 CCA patients, finding that about 25% had chronic liver disease and over 10% had cirrhosis.
- The study revealed a stronger association between chronic liver disease and intrahepatic CCA compared to extrahepatic CCA, except for primary sclerosing cholangitis, which was linked to extrahepatic forms.
Background: Preliver transplant diabetes mellitus (pre-LT DM) is a common comorbidity in LT recipients associated with poorer post-transplant survival. However, its relationship with other important outcomes, including cardiovascular and renal outcomes, remains unclear. This meta-analysis aims to provide an updated analysis of the impact of pre-LT DM on key post-LT outcomes.
View Article and Find Full Text PDFBackground And Aims: Non-alcoholic steatohepatitis (NASH) cirrhosis is rapidly growing as an indication for liver transplant(ation) (LT). However, the natural history of NASH cirrhosis among LT waitlist registrants has not been established. The present study aimed to define the natural history of NASH cirrhosis using the Scientific Registry of Transplant Recipients database.
View Article and Find Full Text PDFBackground: The prevalence of liver fibrosis detected by non-invasive imaging in alpha-1-antitrypsin (AAT) deficiency has not been systematically assessed.
Aims: We conducted a systematic review and meta-analysis to determine the prevalence of significant fibrosis and advanced fibrosis in AAT deficiency based on non-invasive imaging.
Methods: Medline and Embase electronic databases were searched for studies from inception to 13 November 2022 that provided data for the prevalence of fibrosis in adults with AAT deficiency.